Resveratrol Derivatives and Their Role as Potassium Channels Modulators

Journal of Natural Products

Volumn 67, Issue 3, 2004, Pages 421-426

  Orsini, F ^a   Verotta, L ^a   Lecchi, M ^b   Restano, R ^b   Curia, G ^b   Redaelli, E ^b   Wanke, E ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF MILANO BICOCCA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BIBENZYL DERIVATIVE; DIHYDRORESVERATROL; POTASSIUM CHANNEL; POTASSIUM CHANNEL AFFECTING AGENT; RESVERATROL; RESVERATROL DERIVATIVE; SODIUM CHANNEL; STILBENE DERIVATIVE; UNCLASSIFIED DRUG; VOLTAGE GATED POTASSIUM CHANNEL;

ANIMAL CELL; ARTICLE; DRUG SYNTHESIS; MOUSE; NONHUMAN; RAT;

ANIMALS; MICE; MOLECULAR STRUCTURE; POTASSIUM CHANNELS, VOLTAGE-GATED; RATS; STEREOISOMERISM; STILBENES; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR CELLS, CULTURED;

ANIMALIA;

EID: 1642546976     PISSN: 01633864     EISSN: None     Source Type: Journal    
DOI: 10.1021/np0303153     Document Type: Article

References (43)

1. (a) Gorham, J. In The Biochemistry of Stilbenoids; Chapman and Hall: London, 1995.
2. (b) Orsini, F.; Verotta, L. Stilbenes and bibenzyls with potential anticancer or chemopreventive activity. In Advances in Nutrition and Cancer II; Zappia V., Della Ragione F., Barbarisi A., Russo G. L., Eds.; Plenum Press: London, UK, 1999; pp 169-186.
3. (a) Fauconneau, B.; Waffo-Teguo P.; Huguet, F.; Barrier, L.; Decendit, A.; Merillon J. M. Life Sci. 1997, 61, 2103-2110.
4. (b) Jang, J.-H.; Surh, Y.-J. Free Radical Biol., Med. 2003, 34, 1100-1110.
5. Frankel, E. N.; Waterhouse, A. L.; Kinsella, J. E. Lancet 1998, 341, 1103-1104.
6. Fontecave, M.; Lepoivre, M.; Elleingand, E.; Gerez, C.; Guitter, O. FEBS Lett. 1998, 421, 277-279.
7. Sun, N. J.; Woo, S. H.; Cassady, J. M.; Snapka, R. M. J. Nat. Prod. 1998, 61, 362-366.
8. (a) Lemeshow, S.; Letenneur, L.; Dartigues, J. F.; Lafont, S.; Orgogozo, J. M.; Commenges, D. Am. J. Epidem. 1998, 148, 298-306.
9. (b) Virgili, M.; Contestabile, A. Neuroscience 2000, 281, 123-126.
10. (a) Pace-Asciak C. R.; Hahn S. E.; Diamandis E. P.; Soleas G.; Goldberg D. M. Clin. Chim. Acta 1995, 235, 207-219.
11. (b) Orsini, F.; Pelizzoni, F.; Verotta, L. Aburjai, T.; Rogers, C. B. J. Nat. Prod. 1997, 60, 1082-1087.
12. Kimura, Y.; Okuda, H.; Arichi, S. Biochim. Biophys. Acta 1985, 834, 275-278.
13. (a) Jang, M.; Cai, L.; Udeani, G. O.; Slowing, C. V.; Thomas, C. F.; Beecher, C. W. W.; Fong, H. S.; Farnsworth, N. R.; Kinghorn, A. D.; Metha, G. R.; Moon, C. R.; Pezzuto, J. M. Science 1997, 275, 218-220.
14. (a) Pelizzoni, F.; Verotta, L.; Rogers, C. B.; Colombo, R.; Pedrotti, B. ; Balconi, G.; Erba, E.; D'Incalci, M. Nat. Prod. Lett. 1993, 1, 273-280.
15. (b) Haar, E.; Rosenkranz, H. S.; Hamel, E.; Day B. W. Bioorg. Med. Chem. 1996, 10, 1659-1671.
16. Grainger, D. J.; Metcalfe, J. C. Nat. Med. 1996, 2, 381-385.
17. (a) Kampa, M.; Hatzoglou, A.; Notas, G.; Daminaki, A.; Bakogeorgou, E.; Gemetzi, C.; Kouroumalis, E.; Martin, P. M.; Castanas, E. Nutr. Cancer 2000, 37(2), 223-233.
18. (b) Bowers, J. L.; Tyulmenkov, V.; Jernigan, S. C.; Klinge, C. M. Endocrinology 2000, 141 (10), 3657-3667.
19. (c) Schneider, Y.; Vincent, F.; Duranton, B.; Badolo, L.; Gosse, F.; Bergmann, C.; Seiler, N.; Raul, F. Cancer Lett. 2000, 158 (1), 85-91.
20. (d) Damianaki, A.; Bakogeorgou, E.; Kampa, M.; Notas, G.; Hatzoglou, A.; Panagiotou, S.; Gemetzi, C.; Kouroumalis, E.; Martin, P. M.; Castanas, E. J Cell Biochem. 2000, 78 (3), 429-441.
21. (e) Lu, J.; Ho, C. T.; Ghai, G.; Chen, K. Y. Carcinogenesis 2001, 22 (2), 321-328.
22. (f) Park, J. W.; Choi, Y. J.; Jang, M. A.; Lee, Y. S.; Jun, D. Y.; Suh, S. I.; Baek, W. K.; Suh, M. H.; Jin, I. N.; Kwon, T. K. Cancer Lett. 2001, 163 (1), 43-49.
23. (g) Della Ragione, R.; Cucciolla, V.; Borriello, A.; Della Pietra, V.; Raciuppi, L.; Soldati, G.; Manna, C.; Galletti, P.; Zappia, V. Biochem. Biophys. Res. Commun. 1998, 250, 53-58.
24. Orsini, F.; Pelizzoni, F.; Bellini, B.; Miglierini, G. Carbohydr. Res. 1997, 301, 95-109.
25. Guatteo, E.; Bianchi, L.; Faravelli, L.; Verotta, L.; Pelizzoni, F.; Rogers, C. B.; Wanke, E. NeuroReport 1996, 7, 2575-2579.
26. 26) evidenced an overall quasi coplanar topography for the lowest energy conformation of trans-resveratrol; however, different orientations of the phenyl rings were accessible at a low energy cost (ΔE ca. 0.1-1.8 kcal/mol) also including the perpendicular ones with respect to the stilbenic double bond. The cis-configuration of the stilbenic double bond destabilizes the coplanar arrangement and forces one of the phenyl rings in an almost perpendicular orientation with respect to the stilbenic double bond. Analysis of dihydroresveratrol evidenced the presence of several quasi-transoid conformations of comparable energy (ΔE between 0.5 and 1.7 kcal/mol) which were different with respect to the orientation of the phenyl rings. Cisoid conformations for dihydroresveratrol were about 5-9 kcal/mol less stable, depending on the orientation of the phenyl rings. Dihydroresveratrol could therefore be able to mimic trans-resveratrol at a very low energy cost. Higher energy (5-9 kcal/ mol in the AM1 scale) would be required to mimic cis-resveratrol, a value, however, that, at least for some orientations of the phenyl rings, should not prevent the molecule from adopting this conformation if required for activity.
27. Faravelli, L.; Arcangeli, A.; Olivotto, M.; Wanke, E. J. Physiol. 1996, 496 (1), 13-23.
28. Hille B. Ionic Channels of Excitable Membranes; Sinauer Associates Inc., 1992.
29. (a) Curran, M. E.; Splawski, I.; Timothy, K. W.; Vincent, G. M.; Green, E. D.; Keating, M. T. Cell 1995, 80, 795-803.
30. (b) Sanguinetti, M. C.; Jiang, C.; Curran, M. E.; Keating, M. T. Cell 1995, 81, 299-307.
31. (a) Chiesa, N.; Rosati, B.; Arcangeli, A.; Olivotto, M.; Wanke, E. J. Physiol. 1997, 501 (2), 313-318.
32. (b) Bauer, C. K.; Schafer, R.; Schiemann, D.; Reid, G.; Hanganu, I.; Schwarz, J. R. Mol. Cell Endocrinol. 1999, 148 (1-2), 37-45.
33. (c) Rosati, B.; Marchetti, P.; Crociani, O.; Lecchi, M.; Lupi, R.; Arcangeli, A.; Olivotto, M.; Wanke, E. FASEB J. 2000, 14, 2601-2610.
34. (a) Bianchi, L.; Wible, B.; Arcangeli, A.; Taglialatela, M.; Morra, F.; Castaldo, P.; Crociani, O.; Rosati, B.; Faravelli, L.; Olivotto, M.; Wanke, E. Cancer Res. 1998, 58 (4), 815-822.
35. (b) Cherubini, A.; Taddei, G. L.; Crociani, O.; Paglierani, M.; Buccoliero, A. M.; Fontana, L.; Noci, I.; Borri, P.; Borrani, E.; Giachi, M.; Becchetti, A.; Rosati, B.; Wanke, E.; Olivotto, M.; Arcangeli, A. Br. J. Cancer 2000, 83 (12), 1722-1729.
36. (a) Fraser, S. P.; Ding, Y.; Liu, A.; Foster, C. S.; Djamgoz, M. B. A. Cell Tissue Res. 1999, 295, 505-512.
37. (b) Yao, X.; Kwan, H. Y. Life Sci. 1999, 65 (1), 55-62.
38. (c) Ouadid-Ahidouch, H.; Chaussade, F.; Roudbaraki, M.; Slomianny, C.; Dewailly, E.; Delcourt, P.; Prevarskaya, N. Biochem. Biophys. Res. Commun. 2000, 278 (2), 272-277.
39. Wu, S.-H. Curr. Med. Chem. 2003, 10, 649-661.
40. Stivala, L. A.; Savio M.; Carafoli, F.; Perucca, P.; Bianchi, L.; Maga, G.; Forti, L.; Pagnoni, U.; Albini, A.; Prosperi, E.; Vannini, V. J. Biol. Chem. 2001, 25, 22568-22594.
41. Platika, D.; Boulos, M. H.; Baizer, L.; Fishman, M. C. Proc. Natl. Acad. Sci. U.S.A. 1985, 82, 3499-3503.
42. Dewar, M. J. S.; Zoebisch, E. G.; Healy, E. F.; Stewart, J. P. J. Am. Chem. Soc. 1985, 107, 3902-3909.
43. Quantum Chemistry Program Exchange n. 527, Indiana University, Bloomington, IN.